PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Renalytix Ai Plc | LSE:RENX | London | Ordinary Share | GB00BYWL4Y04 | ORD 0.25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.50 | 0.29% | 860.00 | 850.00 | 870.00 | 860.00 | 857.50 | 857.50 | 26,568 | 14:58:13 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -10.6 | -16.0 | - | 511 |
Renalytix Ai (RENX) News Headlines
Renalytix Ai News
| Date | Time | Source | Headline |
|---|---|---|---|
| 24/2/2021 | 13:52 | ALNC |  IN BRIEF: Renalytix Partners With Uni Of Utah On Diagnostic Platform |
| 24/2/2021 | 07:00 | UKREG | Renalytix AI PLC University of Utah Kidney Health Partnership |
| 23/2/2021 | 07:00 | UKREG | Renalytix AI PLC Notice of Results |
| 04/2/2021 | 07:00 | RNSNON | Renalytix AI PLC ASN & Renalytix to Co-Host Capital Markets Day |
| 13/1/2021 | 16:35 | UKREG | Renalytix AI PLC Price Monitoring Extension |
| 13/1/2021 | 11:16 | ALNC | Renalytix Notes New Medicare Coverage Pathway For Breakthrough Tests |
| 13/1/2021 | 07:00 | UKREG | Renalytix AI PLC Finalization of MCIT rule for coverage pathway |
| 05/1/2021 | 16:41 | UKREG | Renalytix AI PLC Second Price Monitoring Extn |
| 05/1/2021 | 16:36 | UKREG | Renalytix AI PLC Price Monitoring Extension |
| 05/1/2021 | 16:05 | ALNC | IN BRIEF: Renalytix, DaVita Partner For Chronic Kidney Disease Program |
1 Year Renalytix Ai Chart |
Intraday Renalytix Ai Chart |
